Clinical correlation of elevated high sensitivity CRP levels with the medical history of obesity, dyslipidemia, diabetes/hyperglycemia, hypertension, and hypercholesterolemia guides the prognostication of MACE and cardiovascular mortality across asymptomatic CVD patients. Here, CRP is linked to diabetes mellitus.